reference/26215276

Predicate	Object
contentType	Journal Article
endingPage	9
issn	1178-203X
issueIdentifier	3
pageRange	553-9
publicationName	Therapeutics and Clinical Risk Management
startingPage	553
bibliographicCitation	Fintini D, Brufani C, Cappa M. Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency. Ther Clin Risk Manag. 2009 Jun;5(3):553–9. PMID: 19707272; PMCID: PMC2724186.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c88cce2630574f206a156ba827aa0f5b http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_405c757d20d41786c5295fb47f271c36 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a4f15a7da62092cd297bd6a1e1f4f53b
date	200907
identifier	https://pubmed.ncbi.nlm.nih.gov/19707272 https://doi.org/10.2147/tcrm.s6178 https://pubmed.ncbi.nlm.nih.gov/PMC2724186
isPartOf	https://portal.issn.org/resource/ISSN/1178-203X http://rdf.ncbi.nlm.nih.gov/pubchem/journal/33049
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Profile of mecasermin for the long-term treatment of growth failure in children and adolescents with severe primary IGF-1 deficiency
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10831 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7695 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_b972b5d726037ca07d19472a4ac78306 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_cd8e67ef15114f06a34d85ae70a7b860 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID3736

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID129621433 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128793026 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128236891

Total number of triples: 29.